Our Mission

We recognize that cancer therapies yield different outcomes for individual patients.

Our mission is to improve patient outcomes through

innovative macrocycle-mediated targeted delivery systems.

We are committed to developing versatile, multi-modal platforms that

enhance the effectiveness of targeted cancer therapies.

Leadership Team

Dr. Jonathan Arambula

Co-founder, CEO & Director

Dr. Jonathan Sessler

Dr. Jonathan Arambula

Co-founder, Director &

Head SAB

Dr. Krystle Karoscik

Dr. Jonathan Arambula

Dr. Krystle Karoscik

Co-founder and COO

Dr. Tarak Mody

Dr. Jonathan Arambula

Dr. Krystle Karoscik

Independent Director

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept